(Q36673777)
Statements
Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells (English)
S Okubo
J Kurebayashi
T Otsuki
Y Yamamoto
1 January 2004
1 reference
1 reference
1 reference
1 reference
1 reference